비교리스트

 카트 문의
시장보고서
상품코드
1439925

신경과 기기 : 세계 시장 인사이트, 경쟁 환경 및 시장 전망(2030년)

Neurology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 신경과 기기 시장 규모는 2024-2030년의 예측 기간 동안 연평균 7.46% 성장할 것으로 예상됩니다. 시장은 전 세계적으로 신경과 기기 규제 승인 증가 등의 요인으로 인해 낙관적인 시장 성장세를 보이고 있습니다. 또한, 사고 및 산업 재해로 인한 두부 외상 증가, 노인 인구 증가, 신경 질환의 유병률 증가 등은 전 세계적으로 다양한 신경기기에 대한 수요를 증가시킬 것으로 예상됩니다. 또한, 신경기기의 안전성, 접근성 및 최종 사용자의 사용 편의성 향상에 대한 관심이 높아짐에 따라 예측 기간(2024-2030년) 동안 신경과 기기 시장의 매출 성장이 크게 증가할 것으로 예상됩니다.

신경과 기기 시장 역학

알츠하이머병(AD), 헌팅턴병(HD), 파킨슨병(PD), 다발성 경화증(MS) 등 치료가 어려운 신경질환의 유병률 증가로 인해 치료와 관리를 위한 보다 안전하고 효율적인 약물 분자의 발견이 요구되고 있습니다. 세계보건기구(WHO)(2022)에 따르면 2020년 전 세계적으로 약 5,500만 명이 치매를 앓고 있으며, 매년 수백만 명의 치매 환자가 발생하고 있으며, WHO(2022)에 따르면 2019년 전 세계적으로 약 850만 명이 파킨슨병(PD)을 앓고 있다고 합니다. 580만 명의 장애 조정 생존 연수를 가져왔습니다고 합니다.

노령인구 증가는 신경과 기기 성장의 또 다른 큰 요인입니다. 세계보건기구(WHO)(2022)에 따르면, 2030년까지 최소 6명 중 1명이 60세 이상이 될 것으로 예측됩니다. 이 자료에 따르면 2050년까지 60세 이상 인구는 약 21억 명에 달할 것으로 예상됩니다. 나이가 들어감에 따라 치매, 뇌졸중 등 다양한 신경 질환에 걸릴 확률이 매우 높아집니다.

따라서 위의 요인들이 종합적으로 2024-2030년의 예측 기간 동안 전체 신경과 기기 시장을 견인할 것으로 보입니다.

그러나 다양한 신경계측기기와 관련된 높은 비용과 위험은 신경계측기기 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.

코로나19 팬데믹 기간 동안 병원 관계자와 대중의 감염 위험을 피하기 위한 봉쇄 조치로 인해 신경과 기기 시장은 부정적인 영향을 받았습니다. 이로 인해 병원 및 클리닉의 신경과가 폐쇄되고 코로나19가 전 세계로 확산됨에 따라 신경외과 수술이 중단되었습니다. 또한 시장공급망, 원자재 및 기타 자원 부족으로 인해 모든 의료기기 제조가 감소했습니다. 그러나 코로나19 백신 개발로 인해 봉쇄령이 완화되고 경제 상황이 정상화되면서 병원, 진료소, 연구소에서 치료 및 진단을 위한 정기적인 외래 진료 등 정상적인 의료 서비스가 재개되면서 신경외과 의료기기 시장의 제품 수요가 다시 회복되고 있습니다.

신경과 기기 시장 부문 분석

신경과 기기 시장의 기기 유형 부문에서는 신경 자극 치료 부문이 2023년 큰 매출 점유율을 차지할 것으로 예상됩니다. 이는 주로 신경 자극 장비와 관련된 주요 이점 때문입니다.

예를 들어, 척수자극기 등 신경자극기기는 신경인성 통증과 척수손상 치료에 매우 효과적입니다.

이 기기들은 특정 심부 피질하, 피질, 대뇌피질, 척수, 두개골, 말초신경의 구조를 표적으로 삼아 신경세포 활동을 수정하거나 조절하여 만성통증, 운동장애, 간질, 파킨슨병 등 수많은 신경질환에 대한 치료 효과를 가져옵니다.

따라서, 이 제품 유형에 대한 수요 증가를 고려하여 수많은 신제품이 시장에 출시되고 있습니다. 예를 들어, 2022년 8월 Abbott는 새로운 척수 자극(SCS) 시스템인 Proclaim(TM) Plus에 대한 미국 식품의약국(FDA)의 승인을 획득했습니다.

NEVRO CORP는 2022년 7월, 통증성 당뇨병성 신경병증(PDN)에 따른 만성 통증 치료를 위한 10kHz 고주파 척수 자극 요법이 미국 FDA의 승인을 받았다고 발표했습니다.

이러한 이유로, 신경 자극 장치와 관련된 장점과 용도, 시장에서의 제품 출시 증가로 인해 이 카테고리는 예측 기간 동안 상당한 성장세를 보이며 전체 세계 신경 장치 시장의 성장에 기여할 것으로 예상됩니다.

이 보고서는 세계 신경과 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 조사 분석하여 전해드립니다.

목차

제1장 신경과 기기 시장 보고서 서론

제2장 신경과 기기 시장 주요 요약

  • 조사 범위
  • 시장 개요
  • 경쟁 평가

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 신경과 기기 시장의 주요 요인 분석

  • 신경과 기기 시장 성장 촉진요인
  • 신경과 기기 시장 성장 억제요인과 과제
  • 신경과 기기 시장 기회

제5장 신경과 기기 시장 : Porter의 Five Forces 분석

제6장 신경과 기기 시장에 대한 COVID-19 COVID-19의 영향 분석

제7장 신경과 기기 시장 레이아웃

  • 기기 유형별
    • 신경 자극 기기
    • 뇌신경 수술 기기
    • 뇌척수액(CSF) 관리 기기
    • 신경 인터벤션
    • 기타
  • 용도별
    • 진단
    • 치료
  • 최종사용자별
    • 병원
    • 전문 클리닉
    • 외래수술센터(ASC)
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 신경과 기기 시장 기업과 제품 개요

  • Abbott
  • B. Braun SE
  • Boston Scientific Corporation
  • Integra LifeSciences
  • LivaNova PLC
  • Medtronic
  • MagstimTMS
  • Penumbra, Inc
  • Stryker
  • MicroPort Scientific Corporation
  • Koninklijke Philips N.V.
  • Rapid Medical
  • Acandis GmbH
  • Cerus Endovascular Inc.
  • Helius Medical Technologies
  • Zimmer Biomet
  • Sense Neuro
  • Natus Medical Incorporated.
  • Braintale SAS
  • Avanos Medical, Inc.

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항과 문의

LSH 24.04.04

Neurology Devices Market By Device Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, And Others ], By Application (Diagnosis And Treatment), By End-User (Hospitals, Speciality Clinics, And Ambulatory Surgical Centers), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence and incidence of brain injury, dementia, alzheimer's diseases, and others, and the rising burden of geriatric population across the globe

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030. The neurology devices market is observing optimistic market growth due to factors such as the rise in the number of regulatory approvals for neurology devices across the globe. Further, the increasing cases of head injuries owing to accidents, workplace injuries, and others, and the rise in the geriatric population coupled with the increasing prevalence of neurological diseases are going to increase the demand for various neurological devices across the globe. Additionally, the growing focus on improving the safety, affordability, and usability of neurology devices for end users is further expected to result in appreciable revenue growth in the neurology devices market during the forecast period (2024-2030).

Neurology Devices Market Dynamics:

The increasing prevalence of hard-to-treat neurological diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and multiple sclerosis (MS) among others will require the discovery of safer and more efficient drug molecules for their treatment and management. As per the World Health Organization (WHO) 2022, worldwide around 55 million people were suffering from dementia in 2020 and every year millions of cases of dementia take place. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years.

The increasing geriatric population is another major factor in the growth of neurology devices. As per the World Health Organization 2022, it is expected that by 2030, out of 6 at least 1 person will have his/her age 60 years or above. As per the same source, by 2050, the number of people aged 60 years or above will be around 2.1 billion. With increasing age, the tendency to suffer from various neurological diseases such as dementia, stroke, and others increases tremendously.

Therefore, the factors stated above collectively will drive the overall neurology devices market during the forecast period from 2024-2030.

However, the high cost and risk associated with various neurology devices may act as a restraint in the neurology devices market growth.

The Neurology Devices Market was negatively impacted during the period of COVID- 19 pandemic owing to the lockdown impositions to avoid the risk of the spread of the disease among hospital personnel and the general public. This led to the closure of neurology departments in hospitals and clinics leading to the suspension of neurological procedures due to the huge spread of COVID-19 infection across the globe. Further, shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all medical devices. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments and diagnosis in hospitals, clinics, and laboratories, thereby bringing the demand for products on track in the neurology devices market.

Neurology Devices Market Segment Analysis:

Neurology Devices Market By Product Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, and Others], By Application (Diagnosis and Treatment), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the Neurology Devices market, the neurostimulation segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the key benefits related to neurostimulation devices.

For instance, neurostimulation devices such as spinal cord stimulators are highly effective in treating neuropathic pain and spinal injuries.

These devices target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modify or modulate neuronal activity and therefore provide therapeutic effects for countless neurological diseases including chronic pain, movement disorders, epilepsy, and Parkinson's disease among others.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For example, In August 2022, Abbott received U.S. Food and Drug Administration (FDA) approval for its new Proclaim(TM) Plus spinal cord stimulation (SCS) system.

In July 2022, NEVRO CORP announced that it has received US FDA clearance for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with painful diabetic neuropathy (PDN).

Therefore, owing to the advantages and applications associated with neurostimulation devices along with the increasing product launches in the market, the category is expected to witness considerable growth eventually contributing to the overall growth of the global neurology devices market during the forecast period.

North America is expected to dominate the overall Neurology Devices Market:

Among all the regions, North America is expected to dominate the global neurology devices in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the rising prevalence of head injuries and neurological diseases including Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population, rising product launches and approvals in the region, the presence of key market players in the region, and others will increase the demand of neurology devices in the given forecast period.

For instance, according to the latest data available from the American Society for Biochemistry and Molecular Biology data published in the year 2023, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. Moreover, as per the above-referenced source and statistics, about 2.8 million people suffer from traumatic brain injury (TBI) each year in the United States from which 2,80,000 result in hospitalizations. Therefore, rising cases of head injuries such as Traumatic Brain Injury (TBI) will increase the demand for neurology devices.

Additionally, as per the latest information provided by Parkinson's Foundation, every year approximately 60,000 people in America are diagnosed with PD. Also, the data provided by GLOBOCAN 2020 says that around 24,538 cancer cases of the brain and central nervous system were recorded in the US in 2020.

Also, the increasing prevalence of Alzheimer's disease in the United States will drive the market for diagnostic devices. As per the data provided by the Alzheimer Association (2023), more than 6 million Americans are living with Alzheimer's. By 2050, this number is projected to rise to nearly 13 million. The increasing prevalence of Alzheimer's disease in the United States will increase the demand for its diagnostics devices, ultimately leading to increased overall market growth.

Therefore, the interplay of the above-mentioned factors would provide a conducive environment for the growth of the North America neurology devices market.

Neurology Devices Market Key Players:

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

Recent Developmental Activities in the Neurology Devices Market:

In May 2022, the US Food and Drug Administration today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer's disease.

In November 2022, Insightec received US FDA approval for a new device intended for treating patients with advanced Parkinson's disease named Exablate Neuro.

In April 2020, Brainquant, a quantitative brain measurement device, launched by Braintale SAS received CE mark approval for managing patients in a coma following brain injury.

Key Takeaways from the Neurology Devices Market Report Study

  • Market size analysis for current neurology devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurology Devices market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global neurology devices market.
  • Various opportunities available for the other competitor in the Neurology Devices Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current Neurology Devices Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neurology Devices Market growth in the coming future?

Target Audience who can be benefited from this Neurology Devices Market Report Study

  • Neurology Devices products providers
  • Research organizations and consulting companies
  • Neurology Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Neurology Devices
  • Various end users who want to know more about the neurology devices market and the latest technological developments in the neurology devices market.

Frequently Asked Questions for the Neurology Devices Market:

1. What is a neurology device?

Neurological devices are medical devices that are meant for the diagnosis and treatment of several neurological diseases and include neurostimulation devices, neurosurgery devices, and others.

2. What is the global market for Neurology Devices?

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Neurology Devices market?

The neurology devices market is witnessing positive market growth owing to the increasing prevalence and incidence of brain injury, dementia, Alzheimer's diseases, and others; the rising burden of the geriatric population across the globe, and others will create an exigency in the Neurology Devices market.

4. Who are the key players operating in the global Neurology Devices market?

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

5. Which region has the highest share in the Neurology Devices market?

Among all the regions, North America is estimated to amass a significant revenue share in the global neurology devices market. This can be ascribed to the rising prevalence of head injuries, Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population and the presence of key market players in the region are factors that act as a supportive factors for the North America Neurology Devices Market growth.

Table of Contents

1.Neurology Devices Market Report Introduction

2.Neurology Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neurology Devices Market Key Factors Analysis

  • 4.1. Neurology Devices Market Drivers
    • 4.1.1. Increasing prevalence of neurological diseases
    • 4.1.2. Rising number of traumatic injuries
    • 4.1.3. Increasing demand for minimally invasive surgeries
  • 4.2. Neurology Devices Market Restraints and Challenges
    • 4.2.1. High Cost of these devices
    • 4.2.2. The risk associated with neurology devices
  • 4.3. Neurology Devices Market Opportunities
    • 4.3.1. Expansion of healthcare infrastructure across emerging markets
    • 4.3.2. Increasing research and development activities

5. Neurology Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Neurology DevicesMarket

7. Neurology Devices Market Layout

  • 7.1. By Device Type
    • 7.1.1. Neurostimulation Devices
    • 7.1.2. Neurosurgery Devices
    • 7.1.3. Cerebrospinal Fluid Management Devices
    • 7.1.4. Interventional Neurology
    • 7.1.5. Others
  • 7.2. By Application
    • 7.2.1. Diagnosis
    • 7.2.2. Treatment
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Neurology Devices Market in USD million (2021-2030)
      • 7.3.1.2. Canada Neurology Devices Market in USD million (2021-2030)
      • 7.3.1.3. Mexico Neurology Devices Market in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.2. Germany Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.4. Italy Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.5. Spain Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Neurology Devices Market in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.2. Japan Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.3. India Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.4. Australia Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.5. South Korea Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia Pacific Neurology Devices Market in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Neurology Devices Market in USD million (2021-2030)
      • 7.3.4.2. Africa Neurology Devices Market in USD million (2021-2030)
      • 7.3.4.3. South America Neurology Devices Market in USD million (2021-2030)

8. Neurology Devices Market Company and Product Profiles

  • 8.1. Abbott
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. B. Braun SE
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Integra LifeSciences
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. LivaNova PLC
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. MagstimTMS
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Penumbra, Inc
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Stryker
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Koninklijke Philips N.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Rapid Medical
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Acandis GmbH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Cerus Endovascular Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Helius Medical Technologies
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Zimmer Biomet
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Sense Neuro
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Natus Medical Incorporated.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Braintale SAS
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Avanos Medical, Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제